Have the results of the TOTAL‐trials changed the attitude and practice of maternal‐fetal medicine specialists?
Prenatal Diagnosis · 2023
DOI: 10.1002/pd.6403 ↗Kurz gefasst
Fachartikel in der Zeitschrift Prenatal Diagnosis, 2023. Verfasst von Simen Vergote und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Development and Regeneration Cluster Woman and Child, Biomedical Sciences, KU Leuven, Leuven, Belgium. Hauptthemen laut MEDLINE: Hernias, Diaphragmatic, Congenital, Airway Obstruction. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Wellcome Trust, Great Ormond Street Institute of Child Health, Great Ormond Street Hospital Charity.
Abstract (Originalsprache)
Objective
To explore the views and practices of maternal‐fetal medicine specialists on offering fetoscopic endoluminal tracheal occlusion (FETO) for left‐ and right‐sided congenital diaphragmatic hernia (LCDH, RCDH) in the post Tracheal Occlusion To Accelerate Lung growth (TOTAL)‐trial era.
Method
Cross‐sectional knowledge, attitude and practice survey was conducted among 105 attendees of the 19th World Congress of Fetal Medicine.
Results
On average, respondents were knowledgeable about CDH, involved in research, and provided antenatal treatment options. Four out of five (82%) agreed that neonatal survival in LCDH can be reliably predicted in the prenatal period. Few respondents considered the exact risks and benefits of FETO for severe LCDH as being unclear (16%), yet half were uncertain about this for moderate LCDH (57%) and severe RCDH (45%). Most respondents offer FETO for severe LCDH (97%) and RCDH (79%), but only 59% offer it for moderate LCDH. However, half of respondents (58%) stated that not offering FETO for moderate LCDH would be a psychological burden for parents.
Conclusion
Respondents consider the risk‐benefit ratio of FETO for severe LCDH clear and consistently offer FETO, but not for moderate LDCH and severe RCDH. However, not offering the option of FETO to parents was considered a psychological burden.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Development and Regeneration Cluster Woman and Child, Biomedical Sciences, KU Leuven, Leuven, Belgium.
- Department of Fetal Medicine and Fetal Surgery, National Institute of Perinatology, Mexico City, Mexico.
- Institute of Women's Health, University College of London, London, UK.
- Divisie Vrouw en Baby, Universitair Medisch Centrum Utrecht, Utrecht, The Netherlands.
ORCID-Profile: Simen Vergote, Francesca Maria Russo, David Basurto, Jan Deprest, Neeltje Crombag
Förderung
- Wellcome Trust
- Great Ormond Street Institute of Child Health
- Great Ormond Street Hospital Charity
Zitieren
APA
Vergote, S., Russo, F. M., Basurto, D., Deprest, J., & Crombag, N. (2023). Have the results of the TOTAL‐trials changed the attitude and practice of maternal‐fetal medicine specialists?. Prenatal Diagnosis. https://doi.org/10.1002/pd.6403
Vancouver
Vergote S, Russo FM, Basurto D, Deprest J, Crombag N. Have the results of the TOTAL‐trials changed the attitude and practice of maternal‐fetal medicine specialists?. Prenatal Diagnosis. 2023. doi:10.1002/pd.6403
BibTeX
@article{Vergote2023,
author = {Vergote, Simen and Russo, Francesca Maria and Basurto, David and Deprest, Jan and Crombag, Neeltje},
title = {Have the results of the TOTAL‐trials changed the attitude and practice of maternal‐fetal medicine specialists?},
journal = {Prenatal Diagnosis},
year = {2023},
doi = {10.1002/pd.6403}
}
EUVIMED